Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short-Term Methotrexate with Efalizumab in Psoriasis
NCT00368654Phase 2Completed
- Sponsor
- University of California, Davis
- Start
- Jan 2007
- Primary completion
- May 2008
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of efalizumab in plaque psoriasis, sponsored by University of California, Davis. Started Jan 2007; status: completed.
02
Drugs
efalizumab
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT00368654.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00368654.